Status:
RECRUITING
Comparing Diagnostic Accuracy of High-end Intestinal Ultrasound Versus Mid-end Ultrasound With Tandem Ileo-colonoscopy in Inflammatory Bowel Disease : a Paired, Validating Confirmatory Study
Lead Sponsor:
Asian Institute of Gastroenterology, India
Conditions:
Inflammatory Bowel Disease (IBD)
Eligibility:
All Genders
18-75 years
Phase:
NA
Brief Summary
The HUMID Study (High-end vs. Mid-end Ultrasound in IBD Diagnostics) is a prospective, cross-sectional, paired diagnostic accuracy study evaluating the performance of mid-end versus high-end intestina...
Detailed Description
The HUMID Study (High-end versus Mid-end Ultrasound in Inflammatory Bowel Disease Diagnostics) is a prospective, cross-sectional, paired diagnostic accuracy study designed to compare the performance o...
Eligibility Criteria
Inclusion
- Patients aged 18-75 years.
- Confirmed diagnosis of inflammatory bowel disease (IBD), specifically with ileocolonic involvement.
- Clinically stable at the time of assessment.
- Willing and able to undergo both intestinal ultrasound (IUS) assessments (mid-end and high-end) and the reference standard ileo-colonoscopy.
- Provides informed consent to participate in the study.
Exclusion
- Pregnant or breastfeeding individuals.
- Patients with contraindications to ileo-colonoscopy (e.g., severe comorbidities, known intolerance).
- Individuals unable to provide informed consent.
- Patients with conditions interfering with ultrasound imaging, such as severe obesity or uncooperative behaviour
Key Trial Info
Start Date :
September 14 2024
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
October 30 2025
Estimated Enrollment :
500 Patients enrolled
Trial Details
Trial ID
NCT06938295
Start Date
September 14 2024
End Date
October 30 2025
Last Update
July 16 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Asian Institute of Gastroenterology
Hyderabad, Telangana, India, 500082